Full text is available at the source.
Abstract
Post-operative outcomes after primary total knee or hip arthroplasty may differ between patients prescribed tirzepatide and those prescribed semaglutide.
- Tirzepatide acts on two types of receptors related to insulin and glucagon, while semaglutide specifically targets one.
- The study focuses on comparing the effects of these two medications in a surgical context.
- Patients receiving tirzepatide may experience different recovery patterns compared to those on semaglutide after surgery.
- Outcomes observed will help clarify the role of these medications in post-operative care.
Simplified